Geneva files

Filename
Display:
4.3_Revision of CIPAC MT 190
4.3_Lambda-cyhalothrin WHO 463_CS Proposal
4.2 - CIPAC MT - Superseded Methods_v1
4.1_Problems_regarding_CIPAC_method_Mancozeb_34TCM_and_34WP_M
3.1 - Validation of analytical MT method (1)
2.1 - CIPAC_Presentation_PTZ-desthio_Bayer
2.1 - CIPAC_5252R_Report_PTZ-Desthio_Bayer
2.1 - CIPAC_5251m_Method_PTZ-desthio_Bayer
1.5 - Spinetoram Large Scale Results_May 2020
1.5 - Spinetoram Large Scale Collaborative Trial Report MAY 2020
1.5 - Spinetoram CIPAC Method Report
1.5 - CIPAC Spinetoram Large Scale FINAL May 2020
1.4 - Quizalofop-p-ethyl-CIPAC
1.4 - Quizalofop-p-ethyl-CIPAC-update
1.4 - CIPAC report Quizalofop-p-ethyl
1.4 - CIPAC_report_Quizalofop-P-Ethyl
1.3 - CIPAC_5253_m
1.3 - CIPAC Report Metribuzin 5254
1.3 - CIPAC Metribuzin presentation 2020_Haustein
1.2 - Small scale study of 28-homobrassinolide
1.2 - Small scale study of 28-homobrassinolide
1.2 - 28-Homobrassinolide-CIPAC
1.2 - 28-Homobrassinolide-CIPAC-2020 (1)
1.1 - 5206_R Florasulam-full scale collaborative trial-JAL(V01)
1.1 - 5205_m florasulam-method-JAL(V02)